Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibacterial Effect of TheraCal vs Biner LC in Deep Caries
NCT03214770Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Aug 2018
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (2 arms), sponsored by Cairo University. Primary endpoint: Bacterial Count of Streptococcus Mutans at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03214770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214770.